[1] BARGAGLI M,SCOGLIO M,HOWLES S A,et al.Kidney stone disease:risk factors,pathophysiology and management[J].Nat Rev Nephrol,2025,21(11):794-808. [2] 张天祥,张熙,胡春江,等.微环境在肾结石发病机制中的作用[J].中华泌尿外科杂志,2025,46(10):791-5. [3] 许发明. 五苓散在肾结石治疗中的应用[J].光明中医,2017,32(24):3585-7. [4] TSAI C H,CHEN Y C,CHEN L D,et al.A traditional Chinese herbal antilithic formula,Wulingsan,effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats[J].Urol Res,2008,36(1):17-24. [5] 吴兴华,张树东,朱纪斌.基于网络药理学和分子对接技术的桑黄治疗动脉粥样硬化作用机制研究[J].中国临床药学杂志,2026,35(01):56-64. [6] LUAN Z L,MING W H,SUN X W,et al.A naturally occurring FXR agonist,alisol B 23-acetate,protects against renal ischemia-reperfusion injury[J].American journal of physiology Renal physiology,2021,321(5):F617-f28. [7] JIA X,ZHU H,LI G,et al.Anti-osteoporotic effects of alisol C 23-acetate via osteoclastogenesis inhibition[J].Biomed Pharmacother,2021,137:111321. [8] ALAM M B,CHOWDHURY N S,SOHRAB M H,et al.Cerevisterol Alleviates Inflammation via Suppression of MAPK/NF-kappaB/AP-1 and Activation of the Nrf2/HO-1 Signaling Cascade[J].Biomolecules,2020,10(2). [9] LEE S R,LEE S,MOON E,et al.Bioactivity-guided iso-lation of anti-inflammatory triterpenoids from the sclerotia of Poria cocos using LPS-stimulated Raw264.7 cells[J].Bioorg Chem,2017,70:94-9. [10] DENG J S,HUANG S S,LIN T H,et al.Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from Antrodia camphorata on the inflammatory mediator expression in mice[J].Journal of agricultural and food chemistry,2013,61(21):5064-71. [11] WANG M,HU H H,CHEN Y Y,et al.Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation[J].Phytomedicine,2020,79:153323. [12] YOSHIOKA I,TSUJIHATA M,OKUYAMA A.Effect of sex hormones on crystal formation in a stone-forming rat model[J].Archivio italiano di urologia,andrologia:organo ufficiale[di]Societa italiana di ecografia urologica e ne-frologica,2011,83(1):26-30.